BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 24468069)

  • 1. Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke.
    Boehme AK; Siegler JE; Mullen MT; Albright KC; Lyerly MJ; Monlezun DJ; Jones EM; Tanner R; Gonzales NR; Beasley TM; Grotta JC; Savitz SI; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e255-61. PubMed ID: 24468069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in refusal of stroke thrombolysis in Chicago.
    Mendelson SJ; Aggarwal NT; Richards C; O'Neill K; Holl JL; Prabhakaran S
    Neurology; 2018 Jan; 90(5):e359-e364. PubMed ID: 29298854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Clinical Care and In-Hospital Outcomes of Asian American and White Patients With Acute Ischemic Stroke.
    Song S; Liang L; Fonarow GC; Smith EE; Bhatt DL; Matsouaka RA; Xian Y; Schwamm LH; Saver JL
    JAMA Neurol; 2019 Apr; 76(4):430-439. PubMed ID: 30667466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke.
    Mendelson SJ; Zhang S; Matsouaka R; Xian Y; Shah S; Lytle BL; Solomon N; Schwamm LH; Smith EE; Saver JL; Fonarow G; Holl J; Prabhakaran S
    Neurology; 2022 Apr; 98(16):e1596-e1604. PubMed ID: 35228335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry.
    Messé SR; Khatri P; Reeves MJ; Smith EE; Saver JL; Bhatt DL; Grau-Sepulveda MV; Cox M; Peterson ED; Fonarow GC; Schwamm LH
    Neurology; 2016 Oct; 87(15):1565-1574. PubMed ID: 27629092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Ischemic Stroke Interventions in the United States and Racial, Socioeconomic, and Geographic Disparities.
    de Havenon A; Sheth K; Johnston KC; Delic A; Stulberg E; Majersik J; Anadani M; Yaghi S; Tirschwell D; Ney J
    Neurology; 2021 Dec; 97(23):e2292-e2303. PubMed ID: 34649872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent leukocytosis-is this a persistent problem for patients with acute ischemic stroke?
    Boehme AK; Kumar AD; Lyerly MJ; Gillette MA; Siegler JE; Albright KC; Beasley TM; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1939-43. PubMed ID: 24784010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and ethnic differences in outcomes in older patients with acute ischemic stroke.
    Qian F; Fonarow GC; Smith EE; Xian Y; Pan W; Hannan EL; Shaw BA; Glance LG; Peterson ED; Eapen ZJ; Hernandez AF; Schwamm LH; Bhatt DL
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):284-92. PubMed ID: 23680966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of tissue plasminogen activator eligibility by sex in the Greater Cincinnati/Northern Kentucky Stroke Study.
    Madsen TE; Khoury JC; Alwell KA; Moomaw CJ; Kissela BM; De Los Rios La Rosa F; Woo D; Adeoye O; Flaherty ML; Khatri P; Ferioli S; Kleindorfer D
    Stroke; 2015 Mar; 46(3):717-21. PubMed ID: 25628307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of presenting stroke severity and thrombolysis on outcomes following urgent carotid interventions.
    Hayson A; Burton J; Allen J; Sternbergh WC; Fort D; Bazan HA
    J Vasc Surg; 2023 Sep; 78(3):702-710. PubMed ID: 37330150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-Year Trend in Age, Sex, and Racial Disparity in tPA (Alteplase) and Thrombectomy Use Following Stroke in the United States.
    Otite FO; Saini V; Sur NB; Patel S; Sharma R; Akano EO; Anikpezie N; Albright K; Schmidt E; Hoffman H; Gould G; Khandelwal P; Latorre JG; Malik AM; Sacco RL; Chaturvedi S
    Stroke; 2021 Aug; 52(8):2562-2570. PubMed ID: 34078107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic disparities in the use of intravenous recombinant tissue plasminogen activator and outcomes for acute ischemic stroke.
    Nasr DM; Brinjikji W; Cloft HJ; Rabinstein AA
    J Stroke Cerebrovasc Dis; 2013 Feb; 22(2):154-60. PubMed ID: 22155116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.
    Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D
    J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of racial differences on outcomes after thrombolytic therapy in acute ischemic stroke.
    Mishra NK; Mandava P; Chen C; Grotta J; Lees KR; Kent TA;
    Int J Stroke; 2014 Jul; 9(5):613-7. PubMed ID: 24148895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity.
    Johnston SC; Fung LH; Gillum LA; Smith WS; Brass LM; Lichtman JH; Brown AN
    Stroke; 2001 May; 32(5):1061-8. PubMed ID: 11340210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explicit consideration of baseline factors to assess recombinant tissue-type plasminogen activator response with respect to race and sex.
    Mandava P; Murthy SB; Munoz M; McGuire D; Simon RP; Alexandrov AV; Albright KC; Boehme AK; Martin-Schild S; Martini S; Kent TA
    Stroke; 2013 Jun; 44(6):1525-31. PubMed ID: 23674524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with Low National Institutes of Health Stroke Scale Scores Have Longer Door-to-Needle Times: Analysis of a Telestroke Network.
    Bhatt A; Lesko A; Lucas L; Kansara A; Baraban E
    J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2253-8. PubMed ID: 27266620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.